China Myocardial Infarction Market
China Myocardial Infarction Market Size, Share & Trends Analysis Report by Treatment Type (Pharmacological Treatment, Interventional Procedures, Adjunct & Supportive Care), by Medical Device Type (Left Ventricular Assist Device, Pacemaker, Catheters, Implantable Cardioverter Defibrillator, Others), by End-User (Hospitals, Specialty Centres, ASCs), and Forecast Period (2026–2035)
Industry Overview
China myocardial infarction market was valued at $776.0 million in 2025 and is projected to reach $1,066.0 million by 2035, growing at a CAGR of 8.90% from 2026 to 2035. Myocardial infarction, commonly known as a heart attack, is a critical cardiovascular condition caused by reduced or blocked blood flow to the heart muscle. The market encompasses a broad spectrum of treatment solutions, including pharmacological therapies, interventional procedures such as angioplasty and stenting, and advanced medical devices like pacemakers and implantable cardioverter defibrillators. The rising prevalence of cardiovascular diseases in China, driven by sedentary lifestyles, unhealthy dietary patterns, and a rapidly aging population, is a key factor fueling market growth. Furthermore, the country’s healthcare system is increasingly prioritizing the expansion of emergency cardiac care infrastructure and improving access to advanced treatment technologies, which is further accelerating market development.
Technological advancements are playing a crucial role in enhancing the efficiency and effectiveness of myocardial infarction diagnosis and treatment. In March 2026, Medtronic reported results from its ALERT trial, demonstrating that AI-enabled clinician alerts significantly improved the evaluation and management of patients with cardiovascular conditions, leading to a 40% increase in timely valve interventions. This highlights the growing importance of AI-driven solutions in optimizing clinical decision-making and patient outcomes. Similarly, in August 2025, GE HealthCare introduced the Vivid Pioneer, an advanced AI-powered cardiovascular ultrasound system designed to enhance diagnostic accuracy and streamline clinical workflows. Featuring high-resolution 2D and 4D imaging along with AI-based automation, the system enables faster and more precise cardiac assessments. Such innovations are strengthening early detection and management of myocardial infarction, thereby supporting the overall growth of the market in China.
Market Dynamics
Stent Innovations Accelerating Minimally Invasive Cardiac Care in China
Interventional procedures such as angioplasty and stent placement continue to drive market growth due to their effectiveness in restoring blood flow and reducing mortality. The rising preference for minimally invasive treatments is boosting the adoption of advanced catheter-based technologies. In October 2025, MicroPort announced that its coronary stent systems surpassed 10 million cumulative global shipments and implantations. These stents are widely used across more than 4,000 hospitals in China, supporting large-scale treatment of coronary artery disease. This milestone underscores the growing adoption of stent-based interventions, strengthening myocardial infarction management and the overall medical device market in China.
Next-Gen Pacemakers Transform Cardiac Care Outcomes
Advanced cardiac devices such as implantable cardioverter defibrillators and pacemakers are gaining traction due to their critical role in managing post-myocardial infarction rhythm disorders. In February 2026, Abbott reported real-world evidence for its AVEIR DR dual-chamber leadless pacemaker, highlighting significantly lower complication rates and fewer reinterventions compared to traditional systems. The device demonstrated over 99% implant success along with strong atrioventricular synchrony. These improvements enhance clinical outcomes and patient safety in cardiac rhythm management. Such innovations are accelerating the adoption of advanced implantable devices across China’s cardiac care landscape.
Market Segmentation
- Based on treatment type, the market is segmented into pharmacological treatment, interventional procedures, and adjunct & supportive care.
- Based on medical device type, the market is segmented into left ventricular assist device, pacemaker, catheters, implantable cardioverter defibrillator, and others.
- Based on end-user, the market is segmented into hospitals, specialty centres, and ASCs.
Hospitals at the Forefront of Advanced Cardiac Care
Hospitals continue to dominate the market owing to their advanced infrastructure and access to highly skilled cardiology professionals. Their ability to provide immediate emergency response and comprehensive cardiac care makes them the primary treatment centers for myocardial infarction. The rising number of acute heart attack admissions is further strengthening their position. This surge is driving increased demand for advanced diagnostic systems and interventional devices. As a result, hospitals remain the key end-users shaping market growth and innovation.
Market Players Outlook
The major companies operating in the China myocardial infarction market include Johnson & Johnson, Abbott, Medtronic, Siemens Healthineers, and GE HealthCare, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Development
- In October 2024, Medtronic received FDA approval for its Affera Mapping and Ablation System with Sphere-9 catheter, an all-in-one solution combining high-density mapping with pulsed field and radiofrequency ablation. The system is designed to treat atrial fibrillation and cardiac arrhythmias with improved procedural efficiency and safety outcomes. Such innovations enhance catheter-based cardiac interventions and support advanced treatment pathways associated with myocardial infarction care.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Key companies operating in the chinese myocardial infarction market
- Based on the availability of data, information related to new protections and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- China Myocardial Infarction Market Sales Analysis – Treatment Type | Device Type | End User ($ Million)
- China Myocardial Infarction Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach Analytics
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key China Myocardial Infarction Market Trends
- Market Recommendations
- Market Determinants
- Market Drivers
- Drivers of China Myocardial Infarction Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For China Myocardial Infarction Market: Impact Analysis
- Market Opportunities
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – China Myocardial Infarction Market Revenue and Share by Manufacturers
- China Myocardial Infarction Type Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Johnson & Johnson
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Abbott
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Medtronic
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Siemens Healthineers
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- GE HealthCare
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Johnson & Johnson
- Key Company Analysis
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- China Myocardial Infarction Market Sales Analysis Treatment Type ($ Million)
- Pharmacological Treatment
- Interventional Procedures
- Adjunct & Supportive Care
- China Myocardial Infarction Market Sales Analysis Device Type ($ Million)
- Left Ventricular Assist Device
- Pacemaker
- Catheters
- Implantable Cardioverter Defibrillator
- Others
- China Myocardial Infarction Market Sales Analysis End User ($ Million)
- Hospitals
- Specialty Centres
- ASCs
- Company Profiles
- Beijing Aeonmed Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Beijing Amsino Medical Instruments Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Comen Medical Instruments Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Demax Medical Technology Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- EDAN Instruments, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Guangdong Biolight Meditech Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hongda Medical Equipment Group
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Lepu Medical Technology Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- MicroPort CardioFlow Medtech
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- SCW Medicath Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Shanghai Kindly Medical Instruments Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Shenzhen Creative Industry Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Shenzhen Enmind Technology Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Shenzhen XFT Medical Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Shinva Medical Instrument Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Shunmei Medical Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- SunTech Medical China
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Tianjin Chase Sun Pharmaceutical
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- VDI Medical Technology Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Weigao Group Medical Polymer Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Zhejiang Barty Medical Technology Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Beijing Aeonmed Co., Ltd.
1. China Myocardial Infarction Market Research and Analysis By Treatment Type, 2025-2035($ Million)
2. China Myocardial Infarction Pharmacological Treatment Market Research and Analysis, 2025-2035($ Million)
3. China Myocardial Infarction Interventional Procedures Market Research and Analysis, 2025-2035($ Million)
4. China Myocardial Infarction Adjunct & Supportive Care Market Research and Analysis, 2025-2035($ Million)
5. China Myocardial Infarction Market Research and Analysis By Device Type, 2025-2035($ Million)
6. China Myocardial Infarction Left Ventricular Assist Device Market Research and Analysis, 2025-2035($ Million)
7. China Myocardial Infarction Pacemaker Market Research and Analysis, 2025-2035($ Million)
8. China Myocardial Infarction Catheters Market Research and Analysis, 2025-2035($ Million)
9. China Myocardial Infarction Implantable Cardioverter Defibrillator Market Research and Analysis, 2025-2035($ Million)
10. China Myocardial Infarction Others Market Research and Analysis, 2025-2035($ Million)
11. China Myocardial Infarction Market Research and Analysis By End User, 2025-2035($ Million)
12. China Myocardial Infarction For Hospitals Market Research and Analysis, 2025-2035($ Million)
13. China Myocardial Infarction For Specialty Centres Market Research and Analysis, 2025-2035($ Million)
14. China Myocardial Infarction For ASCs Market Research and Analysis, 2025-2035($ Million)
1. China Myocardial Infarction Market Research and Analysis By Treatment Type, 2025 Vs 2035 ($ Million)
2. China Myocardial Infarction Pharmacological Treatment Market Research and Analysis, 2025 Vs 2035 ($ Million)
3. China Myocardial Infarction Interventional Procedures Market Research and Analysis, 2025 Vs 2035 ($ Million)
4. China Myocardial Infarction Adjunct & Supportive Care Market Research and Analysis, 2025 Vs 2035 ($ Million)
5. China Myocardial Infarction Market Research and Analysis By Device Type, 2025 Vs 2035 ($ Million)
6. China Myocardial Infarction Left Ventricular Assist Device Market Research and Analysis, 2025 Vs 2035 ($ Million)
7. China Myocardial Infarction Pacemaker Market Research and Analysis, 2025 Vs 2035 ($ Million)
8. China Myocardial Infarction Catheters Market Research and Analysis, 2025 Vs 2035 ($ Million)
9. China Myocardial Infarction Implantable Cardioverter Defibrillator Market Research and Analysis, 2025 Vs 2035 ($ Million)
10. China Myocardial Infarction Others Market Research and Analysis, 2025 Vs 2035 ($ Million)
11. China Myocardial Infarction Market Research and Analysis By End User, 2025 Vs 2035 ($ Million)
12. China Myocardial Infarction For Hospitals Market Research and Analysis, 2025 Vs 2035 ($ Million)
13. China Myocardial Infarction For Specialty Centres Market Research and Analysis, 2025 Vs 2035 ($ Million)
14. China Myocardial Infarction For ASCs Market Research and Analysis, 2025 Vs 2035 ($ Million)
- Printable version
- No restriction to number of users within the company
